|
Market Closed -
Swiss Exchange
18:30:26 12/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 124.20 CHF | -1.32% |
|
-0.21% | +13.32% |
| 08-12 | PeptiDream Hits Milestone as Novartis Begins Phase 1 Trial for Cancer Therapy | MT |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| Market Cap | 291B 252B 236B 215B 405B 27,737B 411B 2,777B 1,085B 13,888B 1,092B 1,068B 46,310B | P/E 2026 * |
21.7x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 324B 281B 263B 240B 451B 30,895B 458B 3,093B 1,209B 15,470B 1,216B 1,190B 51,583B | EV / Sales 2026 * |
5.63x | EV / Sales 2027 * | 5.21x |
| Free-Float |
91.66% | Yield 2026 * |
2.85% | Yield 2027 * | 2.98% |
Last Transcript: Novartis AG
| 1 day | -1.32% | ||
| 1 week | -0.21% | ||
| Current month | -1.90% | ||
| 1 month | -0.06% | ||
| 3 months | +7.16% | ||
| 6 months | +0.32% | ||
| Current year | +13.32% |
| 1 week | 123.02 |  | 127.66 |
| 1 month | 121.06 | | 131.5 |
| Current year | 107.68 | | 131.5 |
| 1 year | 96.03 | | 131.5 |
| 3 years | 81.1 | | 131.5 |
| 5 years | 72.84 | | 131.5 |
| 10 years | 65.09 | | 131.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 14/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/17/26 A | Sell | 30,743 | 0.0015% | |||
| 2/10/26 A | Sell | 7,500 | 0.0004% | |||
| 2/9/26 A | Sell | 67,000 | 0.0032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.32% | -0.21% | +29.07% | +36.81% | 295B | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,083B | |
| +0.41% | +1.27% | +50.98% | +50.05% | 626B | |
| -0.53% | +1.04% | +25.23% | +63.46% | 442B | |
| -0.92% | +0.22% | +48.34% | +37.85% | 363B | |
| -1.20% | -2.78% | +5.56% | +6.09% | 248B | |
| +0.45% | +2.05% | +46.04% | +58.54% | 224B | |
| -2.51% | +1.77% | -6.55% | -51.74% | 210B | |
| +0.07% | +3.12% | +13.21% | +69.84% | 168B | |
| -1.16% | +1.94% | +6.73% | -27.00% | 152B | |
| Average | -0.63% | +1.84% | +30.94% | +37.49% | 381.08B | |
| Weighted average by Cap. | -0.29% | +2.30% | +47.53% | +62.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.58B 49.89B 46.75B 42.64B 80.16B 5,492B 81.39B 550B 215B 2,750B 216B 212B 9,170B | 61.12B 52.96B 49.62B 45.26B 85.08B 5,830B 86.39B 584B 228B 2,919B 229B 225B 9,734B |
| Net income | 13.78B 11.94B 11.19B 10.2B 19.18B 1,314B 19.48B 132B 51.43B 658B 51.74B 50.62B 2,194B | 15.36B 13.31B 12.47B 11.37B 21.38B 1,465B 21.71B 147B 57.32B 733B 57.66B 56.41B 2,446B |
| Net Debt | 33.11B 28.69B 26.88B 24.52B 46.1B 3,158B 46.8B 316B 124B 1,581B 124B 122B 5,273B | 27.82B 24.1B 22.58B 20.6B 38.72B 2,653B 39.32B 266B 104B 1,328B 104B 102B 4,430B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | CHF 124.20 | -1.32% | 2,069,949 |
| 11/08/26 | CHF 125.86 | -0.74% | 1,913,995 |
| 10/08/26 | CHF 126.80 | +0.65% | 1,791,666 |
| 07/08/26 | CHF 125.98 | +0.64% | 1,873,459 |
| 06/08/26 | CHF 125.18 | +0.58% | 1,943,271 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
